Peptide payments run on the same four rails as any card sale: gateway, processor, card network, acquiring bank. The difference in this category is that every one of those four has an opinion about you, and the last one can end the arrangement without warning. Tracing a single order shows you where.
The authorisation is the boring part
A customer enters a card. Your gateway passes the details to the processor, the processor routes to the network, the network asks the issuing bank whether the money is there and whether the transaction looks normal. Approval or decline comes back in about a second.
None of that is where research-use sellers get into trouble. The issuing bank barely knows what it is buying. It sees an amount, a merchant descriptor and a merchant category code, and its fraud model cares about the cardholder, not about you.
The one thing worth getting right at this stage is the descriptor. A vague or unfamiliar name on a statement is one of the most reliable causes of the “I do not recognise this” dispute, which is a dispute you lose on avoidability rather than on merit.
So who actually has an opinion about the product?
The acquiring bank, and it forms that opinion before your first sale rather than during it.
The acquirer is the institution that holds the merchant account and carries the loss if you take money and fail to deliver. That is the whole basis of the relationship. Every underwriting question you get asked is a version of one question: if this business disappears next month, who eats the refunds.
Research-use products make that arithmetic harder in a specific way. The buyer’s motivation is often different from the product’s stated purpose, and a buyer who is disappointed for a reason the seller cannot legally address is a buyer who disputes. The peptide industry page covers what an acquirer asks to see before it accepts that exposure.
Your merchant category code shapes some of this too, and it is set at boarding rather than chosen by you. How MCC assignment works covers why the code matters and why arguing about it after the fact rarely goes anywhere.
Why peptide payments get held rather than declined
Because a decline costs the acquirer nothing and a hold protects it.
Once you are boarded, the bank is not re-approving individual sales. It is watching aggregate behaviour: volume against what you projected, average ticket, refund ratio, dispute ratio, and how fast any of those move. A month that looks nothing like the file you were underwritten on triggers a review, and a review usually means funds stop moving while somebody asks questions.
This is the single most misread event in high risk processing. Sellers experience a hold as punishment. The bank experiences it as pausing an outflow while it works out its exposure. Understanding which one is happening changes how you respond, and responding with documentation rather than outrage genuinely shortens it.
Sudden growth is the most common innocent trigger. If a product goes viral and your volume triples, tell your provider before the month closes, not after the hold lands.
What settlement looks like once a reserve is attached
Most research-use accounts settle with a portion withheld. That is not a penalty, it is the bank funding its own risk of future refunds, and it is standard in categories with delayed delivery or elevated disputes.
Practically, it means the money that arrives in your bank account is not the money you sold. Businesses that plan working capital off gross sales get into trouble in month two, every time. Model your cash flow off what lands, hold the reserve as a number you cannot spend, and know the release schedule before you sign. That release schedule is also the thing to check against your business banking setup, since deposits arriving in irregular amounts from an unfamiliar descriptor cause their own problems on the banking side.
What happens when a research-use order is disputed
The cardholder tells their issuer they want the money back. The issuer pulls the funds, and you are notified after the fact with a reason code and a deadline for evidence.
Your defence is documentary and it is decided by what you can produce, not by whether you were right. Proof of delivery, the order record, your published refund terms, the customer service exchange. In this category, one more thing matters: whether your own product page said anything the buyer could reasonably claim was a promise about an outcome.
Ratios matter more than any individual case. Card networks measure disputes against sales and act at thresholds, and crossing one puts you in a monitoring programme that costs money and attention. How those thresholds are calculated is worth knowing before you are near one rather than after.
Do other rails solve this?
Partly, and not in the way most sellers hope.
Bank debit and transfer methods avoid the card dispute system, which is genuinely useful, but they also lose you the buyers who will not use them, and they carry their own reversal and fraud exposure. Offshore acquiring is a real option for some sellers with genuine international operations and a poor fit for anyone hoping it hides a domestic problem. What offshore actually involves is worth reading honestly before treating it as an escape hatch.
None of these replace a working card account. They reduce concentration risk, which is a different and smaller benefit than it sounds like when you are locked out.
Frequently asked questions
Does a better gateway reduce holds? Not directly, but the fraud tools in a gateway built for high risk reduce the events that cause holds. Address verification, velocity limits and manual review queues stop a chunk of the fraudulent orders that later become disputes, and an underwriter reads their presence as mitigation already in place.
Can I run research-use sales through an account boarded for something else? No, and it is one of the fastest routes to a termination for cause. Processing outside your approved business description breaks the agreement you signed, and the closure that follows is the kind that carries a MATCH listing with it.
Is a reserve ever negotiable? The starting terms reflect your file, so the way to influence them is to improve the file: clean statements, documented fulfillment, a published refund path. Reserves are also frequently reviewed after a stretch of stable processing, which is a reasonable conversation to have once you have the history to point at.
How long does the dispute window stay open? Long enough that a month you thought was closed can reopen, which is exactly why reserves exist. Keep delivery evidence and order records well past the point where they feel useful.